Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common stock and additional paid-in capital	Retained earnings	Retained earnings Cumulative Effect, Period of Adoption, Adjustment	Accumulated other comprehensive income (loss)
Beginning balance (in shares) at Dec. 31, 2021			10,998,765
Balance at beginning of period at Dec. 31, 2021	$ 245,657		$ 66,940	$ 180,417		$ (1,700)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	19,702			19,702
Net unrealized gain (loss) on securities available for sale, net of taxes	(31,077)					(31,077)
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax	14					14
Net unrealized gain on cash flow hedging derivative instruments, net of tax	146					146
Comprehensive income (loss)	(11,215)			19,702		(30,917)
Cash dividends declared	(7,278)			(7,278)
Equity compensation expense	412		$ 412
Payment to repurchase common stock (in shares)			(8,643)
Payment to repurchase common stock	(276)			(276)
Issuance of restricted stock (in shares)			27,495
Proceeds from sale of common stock (in shares)			12,619
Proceeds from sale of common stock	$ 385		$ 385
Ending balance (in shares) at Jun. 30, 2022	11,030,236		11,030,236
Balance at end of period at Jun. 30, 2022	$ 227,685		$ 67,737	192,565		(32,617)
Beginning balance (in shares) at Dec. 31, 2021			10,998,765
Balance at beginning of period at Dec. 31, 2021	$ 245,657		$ 66,940	180,417		(1,700)
Ending balance (in shares) at Dec. 31, 2022	11,045,186		11,045,186
Balance at end of period at Dec. 31, 2022	$ 228,923	$ (6,277)	$ 68,545	204,343	$ (6,277)	(43,965)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accounting Standards Update [Extensible List]	Accounting Standards Update 2016-13 [Member]
Beginning balance (in shares) at Mar. 31, 2022			11,024,086
Balance at beginning of period at Mar. 31, 2022	$ 233,646		$ 67,356	186,324		(20,034)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	9,997			9,997
Net unrealized gain (loss) on securities available for sale, net of taxes	(12,734)					(12,734)
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax	5					5
Net unrealized gain on cash flow hedging derivative instruments, net of tax	146					146
Comprehensive income (loss)	(2,586)			9,997		(12,583)
Cash dividends declared	(3,750)			(3,750)
Equity compensation expense	195		$ 195
Payment to repurchase common stock (in shares)			(199)
Payment to repurchase common stock	(6)			(6)
Proceeds from sale of common stock (in shares)			6,349
Proceeds from sale of common stock	$ 186		$ 186
Ending balance (in shares) at Jun. 30, 2022	11,030,236		11,030,236
Balance at end of period at Jun. 30, 2022	$ 227,685		$ 67,737	192,565		(32,617)
Beginning balance (in shares) at Dec. 31, 2022	11,045,186		11,045,186
Balance at beginning of period at Dec. 31, 2022	$ 228,923	$ (6,277)	$ 68,545	204,343	$ (6,277)	(43,965)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	15,365			15,365
Net unrealized gain (loss) on securities available for sale, net of taxes	937					937
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax	5					5
Net unrealized gain on cash flow hedging derivative instruments, net of tax	136					136
Comprehensive income (loss)	16,443			15,365		1,078
Cash dividends declared	(7,643)			(7,643)
Equity compensation expense	398		$ 398
Payment to repurchase common stock (in shares)			(12,379)
Payment to repurchase common stock	(249)			(249)
Issuance of restricted stock (in shares)			33,610
Proceeds from sale of common stock (in shares)			15,383
Proceeds from sale of common stock	$ 408		$ 408
Ending balance (in shares) at Jun. 30, 2023	11,081,800		11,081,800
Balance at end of period at Jun. 30, 2023	$ 232,003		$ 69,351	205,539		(42,887)
Beginning balance (in shares) at Mar. 31, 2023			11,074,182
Balance at beginning of period at Mar. 31, 2023	228,461		$ 68,941	202,036		(42,516)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	7,394			7,394
Net unrealized gain (loss) on securities available for sale, net of taxes	(3,244)					(3,244)
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax	1					1
Net unrealized gain on cash flow hedging derivative instruments, net of tax	2,872					2,872
Comprehensive income (loss)	7,023			7,394		(371)
Cash dividends declared	(3,878)			(3,878)
Equity compensation expense	213		$ 213
Payment to repurchase common stock (in shares)			(555)
Payment to repurchase common stock	(13)			(13)
Proceeds from sale of common stock (in shares)			8,173
Proceeds from sale of common stock	$ 197		$ 197
Ending balance (in shares) at Jun. 30, 2023	11,081,800		11,081,800
Balance at end of period at Jun. 30, 2023	$ 232,003		$ 69,351	$ 205,539		$ (42,887)